k-757 and k-833
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 21, 2022 (NCT05900531)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06019559 | Phase 2 | Sep 15, 2023 | Kallyope Inc. |
| NCT05890950 | Phase 1 | Mar 13, 2023 | Kallyope Inc. |
| NCT05900531 | Phase 1 | Sep 21, 2022 | Kallyope Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kallyope Inc. | For profit | 3 | 3 | 2 | 2022 |
1 organizations
Page 1 / 1